The effect of culture liquid ethyl acetate mycelium extracts of medicinal mushrooms on the viability of human pancreatic cancer cells

International Journal of Medicinal Mushrooms

Volumn 14, Issue 2, 2012, Pages 169-179

  Sharvit, Lital E ^a   Wasser, Solomon P ^a,b   Fares, Fuad ^a  

^a UNIVERSITY OF HAIFA   (Israel)

^b M G KHOLODNY INSTITUTE OF BOTANY   (Ukraine)

Author keywords

Cell viability; Cyathus striatus; Higher basidiomycetes; Medicinal mushrooms; Natural products; Pancreatic cancer

Indexed keywords

ACETIC ACID ETHYL ESTER; CRYSTAL VIOLET; FUNGAL EXTRACT; LACTATE DEHYDROGENASE; ACETIC ACID DERIVATIVE; ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL VIABILITY; COLORIMETRY; CONTROLLED STUDY; CYATHUS; CYATHUS STRIATUS; CYTOTOXICITY TEST; FUNGAL BIOMASS; GROWTH INHIBITION; HUMAN; HUMAN CELL; MEDICINAL MUSHROOM; MYCELIUM; NONHUMAN; PANCREAS ADENOCARCINOMA; AGARICALES; CHEMISTRY; DOSE RESPONSE; PANCREAS TUMOR; TIME; TUMOR CELL LINE;

BASIDIOMYCOTA; CYATHUS STRIATUS;

ACETATES; AGARICALES; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MYCELIUM; PANCREATIC NEOPLASMS; TIME FACTORS;

EID: 84863762706     PISSN: 15219437     EISSN: 19404344     Source Type: Journal    
DOI: 10.1615/IntJMedMushr.v14.i2.50     Document Type: Article

References (45)

1. Boyle P, Levin B. International Agency for Research on Cancer. World cancer report 2008. International Agency for Research on Cancer, Lyon, France; 2008.
2. American Cancer Society. Cancer Facts and Figures 2012. 2012.
3. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10-29.
4. Tan G, Gyllenhaal C, Soejarto DD. Biodiversity as a source of anticancer drugs. Curr Drug Targets. 2006;7(3):265-77.
5. Harvey AL. Natural products in drug discovery. Drug Discov Today. 2008;13(19-20):894-901.
6. Newman DJ. Natural products as leads to potential drugs: an old process or the new hope for drug discovery? J Med Chem. 2008;51(9):2589-99.
7. Wang MW, Hao X, Chen K. Biological screening of natural products and drug innovation in China. Philos Trans R Soc Lond B Biol Sci. 2007;362(1482):1093-105.
8. Wasser SP, Nevo E, Sokolov D, Reshetnikov S, Timor- Tismenetsky M. Dietary supplements from medicinal mushrooms: diversity of types and variety of regulations. Int J Med Mushr. 2000;2(1):1-19.
9. Wasser SP. Medicinal mushroom science: history, current status, future trends, and unsolved problems. Int J Med Mushr. 2010;12(1):1-16.
10. Sliva D, Labarrere C, Slivova V, Sedlak M, Lloyd FP, Jr, Ho NW. Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochem Biophys Res Commun. 2002;298(4):603-12.
11. Muller CI, Kumagai T, O'Kelly J, Seeram NP, Heber D, Koeffler HP. Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells. Leuk Res. 2006;30(7):841-48.
12. Wu JY, Zhang QX, Leung PH. Inhibitory effects of ethyl acetate extract of Cordyceps sinensis mycelium on various cancer cells in culture and B16 melanoma in C57BL/6 mice. Phytomedicine. 2007;14(1):43-49.
13. Lu QY, Sartippour MR, Brooks MN, Zhang Q, Hardy M, Go VL, Li FP, Heber D. Ganoderma lucidum spore extract inhibits endothelial and breast cancer cells in vitro. Oncol Rep. 2004;12(3):659-62.
14. Chung MJ, Chung CK, Jeong Y, Ham SS. Anticancer activity of subfractions containing pure compounds of Chaga mushroom (Inonotus obliquus) extract in human cancer cells and in Balbc/c mice bearing Sarcoma-180 cells. Nutr Res Pract. 2010;4(3):177-82.
15. Smith J, Rowan N, Sullivan R. Medicinal mushrooms. Their therapeutic properties and current medical usage with special emphasis on cancer treatments. Cancer Research UK, University of Strathclyde, Glasgow. 2002.
16. Zaidman BZ, Yassin M, Mahajna J, Wasser SP. Medicinal mushroom modulators of molecular targets as cancer therapeutics. Appl Microbiol Biotechnol. 2005;67(4):453-68.
17. Yassin M, Mahajna JA, Wasser SP. Submerged culture mycelium extracts of higher Basidiomycetes mushrooms selectively inhibit proliferation and induce differentiation of K562 human chronic myelogenous leukemia cells. Int J Med Mushr. 2003;5:261-76.
18. Kim HW, Kim BK. Biomedical triterpenoids of Ganoderma lucidum (Curt.: Fr.) P. Karst. (Aphyllophoromycetideae). Int J Med Mushr. 1999;1:121-38.
19. Wasser SP, Weis AL. Medicinal properties of substances occurring in higher Basidiomycetes mushrooms: current perspectives (Review). Int J Med Mushr. 1999;1:31-62.
20. Shiao MS. Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities, and pharmacological functions. Chem Rec. 2003;3(3):172-80.
21. Wang XM, Yang M, Guan SH, Liu RX, Xia JM, Bi KS, Guo DA. Quantitative determination of six major triterpenoids in Ganoderma lucidum and related species by high performance liquid chromatography. J Pharm Biomed Anal. 2006;41(3):838-44.
22. Khan IA, Alam SS, Jabbar A. Standardization of medium for the production of maximum phytotoxic activity by Fusarium oxysporum f. sp. ciceris. Pak J Biol Sci. 2001;4(11):1374-76.
23. Mickuviene I, Kirveliene V, Juodka B. Experimental survey of non-clonogenic viability assays for adherent cells in vitro. Toxicol In Vitro. 2004;18(5):639-48.
24. Moran JH, Schnellmann RG. A rapid beta-NADH-linked fluorescence assay for lactate dehydrogenase in cellular death. J Pharmacol Toxicol Methods. 1996;36(1):41-44.
25. Goeptar AR, Groot EJ, Scheerens H, Commandeur JN, Vermeulen NP. Cytotoxicity of mitomycin C and adriamycin in freshly isolated rat hepatocytes: the role of cytochrome P450. Cancer Res. 1994;54(9):2411-18.
26. Wasser SP. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol. 2002;60(3):258-74.
27. Wang G, Zhao J, Liu J, Huang Y, Zhong JJ, Tang W. Enhancement of IL-2 and IFN-gamma expression and NK cells activity involved in the anti-tumor effect of ganoderic acid Me in vivo. Int Immunopharmacol. 2007;7(6):864-70.
28. Tang W, Liu JW, Zhao WM, Wei DZ, Zhong JJ. Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells. Life Sci. 2006;80(3):205-11.
29. Rouhana-Toubi A, Wasser SP, Fares F. Ethyl acetate extracts of submerged cultured mycelium of higher Basidiomycetes mushrooms inhibit human ovarian cancer cell growth. Int J Med Mushr. 2009;11(1):29-37.
30. Kimura Y, Tojima H, Fukase S, Takeda K. Clinical evaluation of sizofilan as assistant immunotherapy in treatment of head and neck cancer. Acta Otolaryngol Suppl. 1994;511:192-95.
31. Hsu SC, Ou CC, Li JW, Chuang TC, Kuo HP, Liu JY, Chen CS, Lin SC, Su CH, Kao MC. Ganoderma tsugae extracts inhibit colorectal cancer cell growth via G2/M cell cycle arrest. J Ethnopharmacol. 2008;120(3):394-401.
32. Zhong JJ, Xiao JH. Secondary metabolites from higher fungi: discovery, bioactivity, and bioproduction. Adv Biochem Eng Biotechnol. 2009;113:79-150.
33. Ye M, Liu JK, Lu ZX, Zhao Y, Liu SF, Li LL, Tan M, Weng XX, Li W, Cao Y. Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, inhibits tumor cell growth by inducing apoptosis in vitro. FEBS Lett. 2005;579(16):3437-43.
34. Ye M, Luo X, Li L, Shi Y, Tan M, Weng X, Li W, Liu J, Cao Y. Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, induces cell-cycle arrest in G1 phase via the ERK1/2 pathway. Cancer Lett. 2007;258(2):199-207.
35. Van Laar ES, Roth S, Weitman S, MacDonald JR, Waters SJ. Activity of irofulven against human pancreatic carcinoma cell lines in vitro and in vivo. Anticancer Res. 2004;24(1):59-65.
36. Wang W, Waters SJ, MacDonald JR, Roth C, Shentu S, Freeman J, Von Hoff DD, Miller AR. Irofulven (6-hydroxymethylacylfulvene, MGI 114)-induced apoptosis in human pancreatic cancer cells is mediated by ERK and JNK kinases. Anticancer Res. 2002;22(2A):559-64.
37. McMorris TC, Kelner MJ, Wang W, Moon S, Taetle R. On the mechanism of toxicity of illudins: the role of glutathione. Chem Res Toxicol. 1990;3(6):574-79.
38. McMorris TC, Kelner MJ, Wang W, Yu J, Estes LA, Taetle R. (Hydroxymethyl)acylfulvene: an illudin derivative with superior antitumor properties. J Nat Prod. 1996;59(9):896-99.
39. McMorris TC, Staake MD, Kelner MJ. Synthesis and biological activity of enantiomers of antitumor irofulven. J Org Chem. 2004;69(3):619-23.
40. Johri BN, Brodie HJ. Extracellular production of indolics by the fungus Cyathus. Mycologia. 1971;63(4):736-44.
41. Allbutt AD, Ayer WA, Brodie HJ, Johri BN, Taube H. Cyathin, a new antibiotic complex produced by Cyathus helenae. Can J Microbiol. 1971;17(11):1401-7.
42. Anke T, Oberwinkler F. The striatins-new antibiotics from the basidiomycete Cyathus striatus (Huds. ex Pers.) Willd. J Antibiot (Tokyo). 1977;30(3):221-25.
43. Ayer WA, Reffstrup T. Metabolites of bird's nest fungi. Part 18. New oxygenated cadinane derivatives from Cyathus striatus. Tetrahedron. 1982;38(10):1409-12.
44. Ayer WA, Flanagan RJ, Reffstrup T. Metabolites of bird's nest fungi. 19. New triterpenoid carboxylic acids from Cyathus striatus and Cyathus pygmaeus. Tetrahedron. 1984;40(11):2069-82.
45. Petrova RD, Mahajna J, Reznick AZ, Wasser SP, Denchev CM, Nevo E. Fungal substances as modulators of NF-kappaB activation pathway. Mol Biol Rep. 2007;34(3):145-54.